BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22706706)

  • 61. KCNQ1 mutations associated with Jervell and Lange-Nielsen syndrome and autosomal recessive Romano-Ward syndrome in India-expanding the spectrum of long QT syndrome type 1.
    Vyas B; Puri RD; Namboodiri N; Nair M; Sharma D; Movva S; Saxena R; Bohora S; Aggarwal N; Vora A; Kumar J; Singh T; Verma IC
    Am J Med Genet A; 2016 Jun; 170(6):1510-9. PubMed ID: 27041150
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Congenital long QT syndrome caused by the F275S KCNQ1 mutation: mechanism of impaired channel function.
    Li W; Wang QF; Du R; Xu QM; Ke QM; Wang B; Chen XL; Tian L; Zhang SY; Kang CL; Guan SM; Yang JG; Song ZF
    Biochem Biophys Res Commun; 2009 Feb; 380(1):127-31. PubMed ID: 19167356
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Primary electrical diseases diagnosis, genetic and management.
    Maury P; Duparc A; Mondoly P; Rollin A; Cardin C; Delay M
    Minerva Cardioangiol; 2010 Aug; 58(4):449-83. PubMed ID: 20938412
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low clinical penetrance in causal mutation carriers for cardiac channelopathies.
    Jiménez-Jáimez J; Álvarez M; Algarra M; Macías Ruíz R; Peñas R; Valverde F; Tortajada G; Lorente JA; Melgares R; Tercedor L
    Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):275-81. PubMed ID: 24775617
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutation analysis for the detection of long QT-syndrome (LQTS) associated SNPs.
    J E; T D; M S; M KN; J D; M NW
    Int J Legal Med; 2017 Mar; 131(2):333-338. PubMed ID: 27613431
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.
    Jons C; O-Uchi J; Moss AJ; Reumann M; Rice JJ; Goldenberg I; Zareba W; Wilde AA; Shimizu W; Kanters JK; McNitt S; Hofman N; Robinson JL; Lopes CM
    Sci Transl Med; 2011 Mar; 3(76):76ra28. PubMed ID: 21451124
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Primary hyperparathyroidism and its management in a woman with hereditary long QT syndrome.
    Kennedy R; O'Hagan S; Ahmad J; McKeown PP; Dobson G; Dolan S
    Ulster Med J; 2007 Sep; 76(3):168-70. PubMed ID: 17853647
    [No Abstract]   [Full Text] [Related]  

  • 68. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.
    Shamgar L; Ma L; Schmitt N; Haitin Y; Peretz A; Wiener R; Hirsch J; Pongs O; Attali B
    Circ Res; 2006 Apr; 98(8):1055-63. PubMed ID: 16556865
    [TBL] [Abstract][Full Text] [Related]  

  • 69. KV7 channelopathies.
    Maljevic S; Wuttke TV; Seebohm G; Lerche H
    Pflugers Arch; 2010 Jul; 460(2):277-88. PubMed ID: 20401729
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mutation Analysis of KCNQ1, KCNH2 and SCN5A Genes in Taiwanese Long QT Syndrome Patients.
    Chang YS; Yang YW; Lin YN; Lin KH; Chang KC; Chang JG
    Int Heart J; 2015; 56(4):450-3. PubMed ID: 26118593
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Short QT syndrome].
    Wolpert C; Schimpf R; Veltmann C; Borggrefe M
    Herz; 2007 May; 32(3):206-10. PubMed ID: 17497253
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Mutation analysis of a Chinese family with inherited long QT syndrome].
    Du R; Yang JG; Li W; Gui L; Yuan GH; Kang CL; Ren FX; Zhang SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):68-70. PubMed ID: 15696484
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Novel Peptide/Antibody-Based Antiarrhythmic Approach to Long QT Syndrome and Beyond.
    Boutjdir M; Lazzerini PE
    J Am Coll Cardiol; 2020 May; 75(17):2153-2155. PubMed ID: 32354383
    [No Abstract]   [Full Text] [Related]  

  • 74. Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.
    Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
    Biochim Biophys Acta; 2011 Apr; 1812(4):488-94. PubMed ID: 21241800
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.
    Leren IS; Hasselberg NE; Saberniak J; Håland TF; Kongsgård E; Smiseth OA; Edvardsen T; Haugaa KH
    JACC Cardiovasc Imaging; 2015 May; 8(5):501-510. PubMed ID: 25890583
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long QT syndrome.
    Jackson H; Huisman LA; Sanatani S; Arbour LT
    CMAJ; 2011 Aug; 183(11):1272-5. PubMed ID: 21482651
    [No Abstract]   [Full Text] [Related]  

  • 77. Novel Gain-of-Function Variant in
    Kelu Bisabu K; Zhao J; Mokrane AE; Segura É; Marsolais M; Grondin S; Naas E; Gagnon J; Cadrin-Tourigny J; Aguilar M; Mongeon FP; Talajic M; Parent L; Tadros R
    Circ Genom Precis Med; 2020 Dec; 13(6):e003123. PubMed ID: 33191761
    [No Abstract]   [Full Text] [Related]  

  • 78. Identification of a Novel KCNQ1 Frameshift Mutation and Review of the Literature among Iranian Long QT Families.
    Amirian A; Zafari Z; Karimipoor M; Kordafshari A; Dalili M; Saber S; Farjam Fazelifar A; Zeinali S
    Iran Biomed J; 2019 May; 23(3):228-34. PubMed ID: 30797226
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A molecular mechanism for adrenergic-induced long QT syndrome.
    Wu J; Naiki N; Ding WG; Ohno S; Kato K; Zang WJ; Delisle BP; Matsuura H; Horie M
    J Am Coll Cardiol; 2014 Mar; 63(8):819-27. PubMed ID: 24184248
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular autopsy for sudden unexplained death? Time to discuss pros and cons.
    Mazzanti A; Priori SG
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1099-102. PubMed ID: 22966897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.